On November 2, 2022 Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel class of tumor-directed oncolytic immunotherapies, reported that members from the Replimune management team will present and host investor meetings at the following two conferences (Press release, Replimune, NOV 2, 2022, View Source [SID1234622790]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BMO Biopharma Spotlight Series Oncology Day
Date: Wednesday, November 9, 2022
Fireside Chat Time: 7:30 am EST

13th Annual Jefferies Global Healthcare Conference
Date: Wednesday, November 16, 2022
Fireside Chat Time: 1:30 pm GMT

A live webcast and replay of the fireside chat at the 13th Annual Jefferies Global Healthcare Conference will also be available in the Investors section of Replimune’s website at www.replimune.com.